Biopharmx (BPMX) Announces Earnings Results, Beats Estimates By $0.01 EPS
Biopharmx (NYSEAMERICAN:BPMX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.01, Fidelity Earnings reports. The firm had revenue of $0.01 million for the quarter.
Shares of Biopharmx stock remained flat at $$0.10 on Friday. 4,958,340 shares of the stock traded hands, compared to its average volume of 4,486,990. Biopharmx has a 12 month low of $0.05 and a 12 month high of $0.33.
Biopharmx Company Profile
Featured Article: Cryptocurrencies
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.